Elite Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
Elite Pharmaceuticals, Inc. (ELTP) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent of -0.33% for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther · last filed 2026-06-29
- Elite Pharmaceuticals, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2026 was -0.33%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month |
|---|---|
| 2026-03-31 | -0.33% 10-K · filed 2026-06-29 |